These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2538095)

  • 41. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Varicella-zoster antibody titers in children with leukemia and lymphoma. Relationship of titer to varicella-zoster infection.
    Hutter JJ; Minnich LL; Ray CG
    Am J Dis Child; 1984 Jan; 138(1):56-9. PubMed ID: 6318551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.
    Hacham M; Leventon-Kriss S; Sarov I
    Intervirology; 1980; 13(4):214-22. PubMed ID: 6248482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
    Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
    J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of antibody to varicella-zoster virus by competitive and IgM-antibody capture immunoassay.
    Tedder RS; Mortimer PP; Lord RB
    J Med Virol; 1981; 8(2):89-101. PubMed ID: 6271923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.
    Anugulruengkitt S; Puthanakit T; Siengboon S; Paitoonpong L; Kowitdamrong E; Pancharoen C; Pichitchok Y
    Jpn J Infect Dis; 2017 Mar; 70(2):216-218. PubMed ID: 27580582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
    van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
    Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.
    Baba K; Shiraki K; Kanesaki T; Yamanishi K; Ogra PL; Yabuuchi H; Takahashi M
    J Clin Microbiol; 1987 Nov; 25(11):2193-6. PubMed ID: 2826535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
    Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention and control of varicella-zoster infections in healthcare facilities.
    Weber DJ; Rutala WA; Hamilton H
    Infect Control Hosp Epidemiol; 1996 Oct; 17(10):694-705. PubMed ID: 8899447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The epidemiologic significance of varicella].
    Hofmann F; Sydow B; Michaelis M
    Gesundheitswesen; 1994 Nov; 56(11):599-601. PubMed ID: 7819671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.